LU87208A1 - Composition permettant d'administrer un medicament sous forme de gelules,d'une poudre ou d'un liquide - Google Patents

Composition permettant d'administrer un medicament sous forme de gelules,d'une poudre ou d'un liquide Download PDF

Info

Publication number
LU87208A1
LU87208A1 LU87208A LU87208A LU87208A1 LU 87208 A1 LU87208 A1 LU 87208A1 LU 87208 A LU87208 A LU 87208A LU 87208 A LU87208 A LU 87208A LU 87208 A1 LU87208 A1 LU 87208A1
Authority
LU
Luxembourg
Prior art keywords
fat
composition according
composition
polymer
methylene chloride
Prior art date
Application number
LU87208A
Other languages
English (en)
French (fr)
Inventor
Esko Marttila
Kari Vahervuo
Ilkka Larma
Jaakko Uotila
Original Assignee
Orion Yhtymae Oy
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Orion Yhtymae Oy filed Critical Orion Yhtymae Oy
Publication of LU87208A1 publication Critical patent/LU87208A1/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
LU87208A 1987-05-08 1988-05-06 Composition permettant d'administrer un medicament sous forme de gelules,d'une poudre ou d'un liquide LU87208A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FI872051 1987-05-08
FI872051A FI77573C (fi) 1987-05-08 1987-05-08 Ny konsistens.

Publications (1)

Publication Number Publication Date
LU87208A1 true LU87208A1 (fr) 1988-12-13

Family

ID=8524451

Family Applications (1)

Application Number Title Priority Date Filing Date
LU87208A LU87208A1 (fr) 1987-05-08 1988-05-06 Composition permettant d'administrer un medicament sous forme de gelules,d'une poudre ou d'un liquide

Country Status (35)

Country Link
US (1) US4935247A (it)
JP (1) JPS63287720A (it)
KR (1) KR880013551A (it)
AT (1) AT396329B (it)
AU (1) AU610161B2 (it)
BE (1) BE1000785A3 (it)
CH (1) CH675070A5 (it)
CS (1) CS270588B2 (it)
DD (1) DD284600A5 (it)
DE (1) DE3815562A1 (it)
DK (1) DK247588A (it)
EG (1) EG18603A (it)
ES (1) ES2006649A6 (it)
FI (1) FI77573C (it)
FR (1) FR2630912B1 (it)
GB (1) GB2204241B (it)
GR (1) GR1000303B (it)
HU (1) HU198621B (it)
IL (1) IL86313A (it)
IS (1) IS3339A7 (it)
IT (1) IT1219691B (it)
LU (1) LU87208A1 (it)
MA (1) MA21264A1 (it)
MX (1) MX167185B (it)
NL (1) NL8801185A (it)
NO (1) NO881993L (it)
NZ (1) NZ224529A (it)
PH (1) PH24652A (it)
PL (1) PL272295A1 (it)
PT (1) PT87429B (it)
RO (1) RO101402B (it)
RU (1) RU1836082C (it)
SE (1) SE8801732L (it)
YU (1) YU46457B (it)
ZA (1) ZA883239B (it)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH01299226A (ja) * 1988-05-27 1989-12-04 Seikagaku Kogyo Co Ltd サラゾスルファピリジン腸溶顆粒
NO882653D0 (no) * 1988-06-15 1988-06-15 Apothekernes Lab Doseringsform.
US5296236A (en) * 1988-09-16 1994-03-22 Recordati S.A., Chemical And Pharmaceutical Company Controlled release therapeutic system for a liquid pharmaceutical formulations
EP0376331A3 (en) * 1988-12-29 1991-03-13 Asahi Kogaku Kogyo Kabushiki Kaisha Slow release drug delivery granules and process for production thereof
US5093128A (en) * 1989-07-18 1992-03-03 Draguesku Oliver J Rumen and other stomach chamber bypass nutrients and methods of fabrication
JP3078859B2 (ja) * 1990-02-23 2000-08-21 武田薬品工業株式会社 安定な放出制御性製剤用コーティング剤
US5084287A (en) * 1990-03-15 1992-01-28 Warner-Lambert Company Pharmaceutically useful micropellets with a drug-coated core and controlled-release polymeric coat
DE4200821A1 (de) * 1992-01-15 1993-07-22 Bayer Ag Geschmacksmaskierte pharmazeutische mittel
GB9201639D0 (en) * 1992-01-25 1992-03-11 Smithkline Beecham Plc Pharmaceutical formulations
EP0689840A1 (de) * 1994-06-28 1996-01-03 Spirig Ag Pharmazeutische Präparate Neues orales Erythromycinbase enthaltendes Arzneimittel
US20060116330A1 (en) * 1997-07-08 2006-06-01 The Iams Company Methods of mimicking the metabolic effects of caloric restriction by administration of mannoheptulose
US20020035071A1 (en) * 1997-07-08 2002-03-21 Josef Pitha Mimicking the metabolic effects of caloric restriction by administration of glucose antimetabolites
US8563522B2 (en) * 1997-07-08 2013-10-22 The Iams Company Method of maintaining and/or attenuating a decline in quality of life
US6242019B1 (en) 1997-08-14 2001-06-05 Warner-Lambert Company Taste modified hard confectionery compositions containing functional ingredients
FR2821745B1 (fr) * 2001-03-09 2004-07-02 Ethypharm Lab Prod Ethiques Granules et granules enrobes au gout masque
FR2821747B1 (fr) * 2001-03-09 2004-07-02 Ethypharm Lab Prod Ethiques Suspension de telithromycine a gout masque
US8168170B2 (en) * 2002-10-03 2012-05-01 The Procter And Gamble Company Compositions having an inner core and at least three surrounding layers
US7785635B1 (en) 2003-12-19 2010-08-31 The Procter & Gamble Company Methods of use of probiotic lactobacilli for companion animals
US8894991B2 (en) * 2003-12-19 2014-11-25 The Iams Company Canine probiotic Lactobacilli
US20050158294A1 (en) * 2003-12-19 2005-07-21 The Procter & Gamble Company Canine probiotic Bifidobacteria pseudolongum
US20050152884A1 (en) * 2003-12-19 2005-07-14 The Procter & Gamble Company Canine probiotic Bifidobacteria globosum
US8877178B2 (en) 2003-12-19 2014-11-04 The Iams Company Methods of use of probiotic bifidobacteria for companion animals
US20050202079A1 (en) * 2004-03-15 2005-09-15 Mylan Pharmaceuticals Inc. Novel orally administrable formulation of nitrofurantoin and a method for preparing said formulation
BRPI0611492B1 (pt) * 2005-05-31 2021-10-13 Mars, Incorporated Bifidobactéria probiótica felina
CA2609617C (en) * 2005-05-31 2014-07-08 The Iams Company Feline probiotic lactobacilli
PL2124966T3 (pl) 2007-02-01 2016-01-29 Iams Europe B V Sposób zmniejszania reakcji zapalnej i stresu u ssaków za pomocą antymetabolitów glukozy, awokado lub ekstraktów awokado
US9771199B2 (en) 2008-07-07 2017-09-26 Mars, Incorporated Probiotic supplement, process for making, and packaging
US10104903B2 (en) 2009-07-31 2018-10-23 Mars, Incorporated Animal food and its appearance

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE835500C (de) * 1950-05-18 1952-03-31 Otto Doerr Dipl Ing Verfahren zum Konservieren eines in einem indifferenten Koerper gespeicherten, im Darm zur Wirkung zu bringenden Mittels
US2828206A (en) * 1954-02-24 1958-03-25 Roseuberg Adolf Stabilized fat-soluble vitamins and methods of making same
US2963402A (en) * 1955-01-18 1960-12-06 Nysco Lab Inc Sustained release medicament
GB821790A (en) * 1956-11-20 1959-10-14 Smith Kline French Lab Method of preparing sustained release particles and the product of the method
US2921883A (en) * 1957-05-03 1960-01-19 Smith Kline French Lab Novel coating material for medicaments
NL122039C (it) * 1960-10-20
BE636568A (it) * 1961-01-31
BE640616A (it) * 1962-12-19
US3256153A (en) * 1963-02-08 1966-06-14 Smith Kline French Lab Method of stabilizing wax-fat coating materials and product thereof
US3432593A (en) * 1963-09-18 1969-03-11 Key Pharm Inc Delayed and sustained release type pharmaceutical preparation
US4330338A (en) * 1978-10-02 1982-05-18 Purdue Research Foundation Pharmaceutical coating composition, and preparation and dosages so coated
IT1148784B (it) * 1980-04-09 1986-12-03 Eurand Spa Procedimento per la preparazione di microcapsule in un veicolo liquido
NZ210785A (en) * 1984-01-13 1987-11-27 Battelle Development Corp Liquid dispersions of layered controlled release dosage forms
US4650665A (en) * 1985-02-08 1987-03-17 Ethicon, Inc. Controlled release of pharmacologically active agents from an absorbable biologically compatible putty-like composition
EP0302065B1 (en) * 1986-03-21 1994-08-10 Eurasiam Laboratories, Inc. Pharmaceutical compositions

Also Published As

Publication number Publication date
DD284600A5 (de) 1990-11-21
SE8801732D0 (sv) 1988-05-06
DE3815562A1 (de) 1988-11-24
HUT48458A (en) 1989-06-28
AU1567288A (en) 1988-11-10
BE1000785A3 (fr) 1989-04-04
GR880100297A (en) 1989-02-23
PH24652A (en) 1990-09-07
ES2006649A6 (es) 1989-05-01
EG18603A (en) 1993-06-30
IL86313A0 (en) 1988-11-15
ZA883239B (en) 1989-07-26
ATA119188A (de) 1992-12-15
RU1836082C (ru) 1993-08-23
DK247588A (da) 1988-11-09
IT1219691B (it) 1990-05-24
MA21264A1 (fr) 1988-12-31
IT8820479A0 (it) 1988-05-06
NZ224529A (en) 1990-02-26
AU610161B2 (en) 1991-05-16
GR1000303B (el) 1992-05-12
NO881993L (no) 1988-11-09
AT396329B (de) 1993-08-25
US4935247A (en) 1990-06-19
GB8810765D0 (en) 1988-06-08
FI872051A (fi) 1988-11-09
FI77573C (fi) 1989-04-10
CH675070A5 (it) 1990-08-31
GB2204241B (en) 1991-02-20
MX167185B (es) 1993-03-09
HU198621B (en) 1989-11-28
PT87429A (pt) 1989-05-31
FI77573B (fi) 1988-12-30
IS3339A7 (is) 1988-08-31
PT87429B (pt) 1992-09-30
FR2630912B1 (fr) 1991-04-12
FR2630912A1 (fr) 1989-11-10
IL86313A (en) 1991-08-16
NO881993D0 (no) 1988-05-06
KR880013551A (ko) 1988-12-21
NL8801185A (nl) 1988-12-01
FI872051A0 (fi) 1987-05-08
RO101402B (ro) 1992-01-13
DK247588D0 (da) 1988-05-06
JPS63287720A (ja) 1988-11-24
SE8801732L (sv) 1988-11-09
CS270588B2 (en) 1990-07-12
YU46457B (sh) 1993-10-20
PL272295A1 (en) 1989-11-13
CS310288A2 (en) 1989-11-14
GB2204241A (en) 1988-11-09
YU83188A (en) 1989-12-31

Similar Documents

Publication Publication Date Title
LU87208A1 (fr) Composition permettant d'administrer un medicament sous forme de gelules,d'une poudre ou d'un liquide
CA2428782C (fr) Medicament a base de microcapsules d'anti-hyperglycemiant a liberation prolongee et son procede de preparation
EP2349217B1 (fr) Granulé d'acide gamma-hydroxybutyrique
EP1492511B1 (fr) Formulation pharmaceutique orale sous forme de suspension aqueuse de microcapsules permettant la liberation modifiee de principe(s) actif(s)
EP0256933B1 (fr) Procédé de préparation d'un médicament à base de fénofibrate, médicament obtenu par ce procédé
CA2447926C (fr) Forme pharmaceutique orale antidiabetique "une prise par jour" comprenant une biguanide et au moins un autre principe actif
EP1492531B3 (fr) Formulation pharmaceutique orale sous forme de suspension aqueuse de microcapsules permettant la liberation modifiée d'amoxicilline
HU227971B1 (en) Tramadol multiple unit formulations and process for producing them
CH647676A5 (fr) Formes galeniques a usage oral, a liberation programmee et leurs procedes de preparation.
FR2725623A1 (fr) Microcapsules medicamenteuses et/ou nutritionnelles pour administration per os
EP0624371A1 (fr) Microcapsules pour la libération contrôlée d'acide acétylsalicylique
EP3277267B1 (en) Enteric-coated pellets containing a proton pump inhibitor
WO2010015754A1 (fr) Composition pharmaceutique sous forme de granules et procede de fabrication d'une telle composition pharmaceutique
BE897221A (fr) Produits a effet prolonge contenant du suloctidil
FR2967576A1 (fr) Composition pharmaceutique comprenant du sel precurseur du cycle de krebs, en particulier du sel de citrate, et son utilisation comme medicament
FR2967577A1 (fr) Composition pharmaceutique comprenant du sel de bicarbonate, et son utilisation comme medicament
FR2959129A1 (fr) Particules comprenant du 4-phenylbutyrate de sodium, procede de preparation et utilisations
FR2932485A1 (fr) Polymere a liberation colique specifique quel que soit le ph
FR2477015A1 (fr) Composition pharmaceutique a base d'un alcaloide de l'ergot de seigle, a activite regulatrice sur le tonus vasculaire
FR2843880A1 (fr) Formulation pharmaceutique orale sous forme de suspension aqueuse de microcapsules permettant la liberation modifiee d'amoxicilline
FR2882255A1 (fr) Spheroides prepares a partir d'un principe actif isole d'origine vegetale et d'une solution d'origine vegetale contenant le principe actif ou un precurseur de celui-ci
FR2724112A1 (fr) Composition contenant l'association du facteur intrinseque et de l'insuline
FR2843881A1 (fr) Formulation pharmaceutique orale sous forme de suspension aqueuse de microcapsules permettant la liberation modifiee de principe(s) actif(s)

Legal Events

Date Code Title Description
DT Application date
TA Annual fee